858 related articles for article (PubMed ID: 28735160)
1. Longitudinal assessment of gait quality in children with bilateral cerebral palsy following repeated lower limb intramuscular Botulinum toxin-A injections.
Read FA; Boyd RN; Barber LA
Res Dev Disabil; 2017 Sep; 68():35-41. PubMed ID: 28735160
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of group versus individual physiotherapy following lower limb intra-muscular Botulinum Toxin-Type A injections for ambulant children with cerebral palsy: A single-blind randomized comparison trial.
Thomas RE; Johnston LM; Sakzewski L; Kentish MJ; Boyd RN
Res Dev Disabil; 2016; 53-54():267-78. PubMed ID: 26955912
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.
Lukban MB; Rosales RL; Dressler D
J Neural Transm (Vienna); 2009 Mar; 116(3):319-31. PubMed ID: 19142573
[TBL] [Abstract][Full Text] [Related]
4. Intramuscular botulinum toxin prior to comprehensive rehabilitation has no added value for improving motor impairments, gait kinematics and goal attainment in walking children with spastic cerebral palsy.
Schasfoort F; Pangalila R; Sneekes EM; Catsman C; Becher J; Horemans H; Stam HJ; Dallmeijer AJ; Bussmann JBJ
J Rehabil Med; 2018 Aug; 50(8):732-742. PubMed ID: 30080235
[TBL] [Abstract][Full Text] [Related]
5. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
[TBL] [Abstract][Full Text] [Related]
6. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin.
Koman LA; Smith BP; Williams R; Richardson R; Naughton M; Griffin L; Evans P
J Hand Surg Am; 2013 Mar; 38(3):435-46.e1. PubMed ID: 23428186
[TBL] [Abstract][Full Text] [Related]
7. Effects of ultrasound-guided botulinum toxin type-A injections with a specific approach in spastic cerebral palsy.
Büyükavcı R; Büyükavcı MA
Acta Neurol Belg; 2018 Sep; 118(3):429-433. PubMed ID: 29694645
[TBL] [Abstract][Full Text] [Related]
8. Treatment with botulinum toxin in children with cerebral palsy: a qualitative study of parents' experiences.
Lorin K; Forsberg A
Child Care Health Dev; 2016 Jul; 42(4):494-503. PubMed ID: 27198886
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A injections for treatment of spastic equinus in cerebral palsy: a secondary analysis of factors predictive of favorable response.
Sätilä H; Huhtala H
Am J Phys Med Rehabil; 2010 Nov; 89(11):865-72. PubMed ID: 20736816
[TBL] [Abstract][Full Text] [Related]
10. Effects of leg muscle botulinum toxin A injections on walking in children with spasticity-related cerebral palsy: a systematic review.
Ryll U; Bastiaenen C; De Bie R; Staal B
Dev Med Child Neurol; 2011 Mar; 53(3):210-6. PubMed ID: 21291464
[TBL] [Abstract][Full Text] [Related]
11. [Botulinum A in the treatment of equinus dynamic spasticity in children with cerebral palsy. Preliminary study].
Mousny M; Allington N
Rev Chir Orthop Reparatrice Appar Mot; 1999 May; 85(2):156-63. PubMed ID: 10392416
[TBL] [Abstract][Full Text] [Related]
12. Injection frequency of botulinum toxin A for spastic equinus: a randomized clinical trial.
Hastings-Ison T; Blackburn C; Rawicki B; Fahey M; Simpson P; Baker R; Graham K
Dev Med Child Neurol; 2016 Jul; 58(7):750-7. PubMed ID: 26589633
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE).
Hoare BJ; Wallen MA; Imms C; Villanueva E; Rawicki HB; Carey L
Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD003469. PubMed ID: 20091546
[TBL] [Abstract][Full Text] [Related]
14. Muscle volume alterations after first botulinum neurotoxin A treatment in children with cerebral palsy: a 6-month prospective cohort study.
Alexander C; Elliott C; Valentine J; Stannage K; Bear N; Donnelly CJ; Shipman P; Reid S
Dev Med Child Neurol; 2018 Nov; 60(11):1165-1171. PubMed ID: 30151852
[TBL] [Abstract][Full Text] [Related]
15. Effects of botulinum toxin serotype A on sleep problems in children with cerebral palsy and on mothers sleep quality and depression.
Binay Safer V; Ozbudak Demir S; Ozkan E; Demircioglu Guneri F
Neurosciences (Riyadh); 2016 Oct; 21(4):331-337. PubMed ID: 27744462
[TBL] [Abstract][Full Text] [Related]
16. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
[TBL] [Abstract][Full Text] [Related]
17. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.
Lin YC; Lin IL; Chou TF; Lee HM
J Neuroeng Rehabil; 2016 Mar; 13():25. PubMed ID: 26969526
[TBL] [Abstract][Full Text] [Related]
18. Reduced Cross-Sectional Muscle Growth Six Months after Botulinum Toxin Type-A Injection in Children with Spastic Cerebral Palsy.
De Beukelaer N; Weide G; Huyghe E; Vandekerckhove I; Hanssen B; Peeters N; Uytterhoeven J; Deschrevel J; Maes K; Corvelyn M; Costamagna D; Gayan-Ramirez G; Van Campenhout A; Desloovere K
Toxins (Basel); 2022 Feb; 14(2):. PubMed ID: 35202166
[TBL] [Abstract][Full Text] [Related]
19. Botulinum Toxin Type A Injection for Spastic Equinovarus Foot in Children with Spastic Cerebral Palsy: Effects on Gait and Foot Pressure Distribution.
Choi JY; Jung S; Rha DW; Park ES
Yonsei Med J; 2016 Mar; 57(2):496-504. PubMed ID: 26847306
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Botulinum Toxin Injections on Gross Motor Function for Lower Limb Spasticity in Children with Cerebral Palsy.
Choi JY; Kim SK; Park ES
Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31717282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]